Skip to main content
29 March 2025
Last updated:
Saturday 29 March 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Trends in investment for cell and gene therapies
Read more
AAV-based gene therapies poised for uplift
Read more
Caszyme pioneers gene editing from Lithuania
Read more
Changes in the landscape for genome editing
Read more
Genome editing for inherited ocular diseases
Read more
The outlook for gene editing in treating disease
Read more
WHO panel advises on governance of genome editing
Read more
VectorY Therapeutics targets misfolded proteins
Read more
A new paradigm for gene therapy
Read more
Addressing the challenges of gene therapy medicinal products
Read more
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form